2020… Get the latest pharmacy news in your inbox. Specialty products and services were considered the most profitable among all the pharmacy trends for this year, and 2020 will see a bigger market for these medications as they become part of the top pharmacy trends for 2020. HOME. A Legacy to Help Others; A Legacy to Help Others. Tafasitamab-cxix should be used with lenalidomide and given on days 1 and 15 of a 28-day cycle after induction therapy. “Even though there was a dip in cancer drug approvals last year with only 11, we’re having a spike this year.” By the end of 2020, the FDA is expected to approve 21 novel cancer drugs, she noted. “Chemotherapy has been the mainstay of treatment for triple-negative breast cancer,” the FDA’s Pazdur said. The data showed that in patients with relapsed cancer, lurbinectedin demonstrated an ORR of 35% and a median DOR of 5.3 months (30%) (Lancet Oncol 2020;21[5]:645-654). CMS Pricing Transparency Rule Looms: Is Your Hospital Ready? “In the past 10 years, there’s been a significant number of new options to treat patients with several specialty conditions,” Tharaldson said at the AMCP Nexus 2020 Virtual meeting, where she highlighted several that were approved this year. We are grieved … In England, a 90-year-old grandmother named Maggie Keenan and an 81-year-old man named William Shakespeare have become the first and second non-trial recipients of Pfizer's COVID-19 vaccine. Amazon Pharmacy is an extension of PillPack, the drugstore startup Amazon bought for more than $700 million in 2018. December 18, 2020 NORTH FORT MYERS, Fla. – A man with a knife was taken into custody after trying to rob a pharmacy inside a North Fort Myers Publix Thursday night. In 2020, Drug Channels Institute will launch a new series of online training videos. About Operation Warp Speed (OWS): The posting of advertisements or solicitation of any kind is prohibited. ABOUT. Fostemsavir (Rukobia, ViiV Healthcare) is a novel oral glycoprotein 120 attachment inhibitor used with other antiretrovirals for the treatment of multidrug-resistant HIV, which affects about 10,000 U.S. patients. Of the 280,000 cases of breast cancer diagnosed each year in the United States, 10% to 15% are triple-negative. Early clinical evidence indicates durable remissions in later lines of therapy, Wang added. Former U.S. Representative and California Attorney General Xavier Becerra—President-elect Joe Biden’s pick for U.S. Department of Health and Human Services (HHS)—is a friend to pharmacy, said California Pharmacists Association (CPhA) CEO Susan Bonilla. National Pharmacy Compliance News. The study assessed the efficacy of treatment 12 hours after the initial dose was given. By Nick Clarkson, Web Editor Nov 17, 2020, 11:54 am EST December 18, 2020 Amazon (NASDAQ: AMZN ) took a major step toward its pharmaceutical service … In fact, about 30% of cancer drugs have an orphan drug designation, indicating a therapy for a condition that affects fewer than 200,000 people. ... 2020. Posted on: December 21, 2020; Updated on: December 21, 2020 We sat down with Gibran Ameer , 2002, CEO of VirtueTechnolgoies, Inc. and VirtueRN, LLC, to learn more about how his experiences with the University of South Carolina College of Pharmacy … on July 29, 2020. CDC’s Advisory Committee on Immunization Practices (ACIP) gave the vaccine its official recommendation on Saturday, December 12, and finalized its endorsement to prioritize COVID-19 vaccination for health care workers—including pharmacists—and residents of long-term-care facilities with the limited supply that will be available initially. Ripretinib (Qinlock, Deciphere), an oral TKI for the fourth-line treatment of advanced GIST, also was approved this year. You could also check thousands of journal abstracts and full-text articles from Medline … The final countdown has begun. If you still see this message after updating your profile, please email our support team, 2020: Truly the Year Of the Specialty Drug. The … In clinical trials, the life span of patients with Hutchinson-Gilford progeria syndrome who were treated with lonafarnib increased by an average of three months through the first three years of treatment, and by an average of 2.5 years through the maximum follow-up of 11 years. Another drug approved for NSCLS is selpercatinib (Retevmo, Loxo Oncology), an oral RET inhibitor, indicated for patients with RET-positive forms of the cancer. December 18, 2020 NORTH FORT MYERS, Fla. – A man with a knife was taken into custody after trying to rob a pharmacy inside a North Fort Myers Publix Thursday night. The treatment of small cell lung cancer (SCLC) also advanced in 2020 with the approval of lurbinectedin (Zepzelca, Jazz/PharmaMar), an alkylating agent that is infused every 21 days. 102. FDA issued an emergency use authorization for the dual treatment on November 19. Decitabine and cedazuridine (Inqovi, Taiho Oncology) is used to treat certain patients with myelodysplastic syndromes. Weighing Risks Vs Benefits. The FDA approved sacituzumab govitecan-hziy based on a clinical trial of 108 patients with metastatic TNBC who had received at least two prior treatments for metastatic disease. New analyses of Pfizer and BioNTech's coronavirus vaccine indicate strong protection against COVID-19 within about 10 days of the first dose, much sooner than initially thought. Novartis estimated that up to 5,000 patients will be candidates annually for this treatment, which is the first drug to be approved for NSCLC caused by the MET mutation. Between 9% and 14% of the 8,000 cases diagnosed each year have FGFR2 mutations. Risdiplam is designed to treat this disorder caused by mutations in chromosome 5q that lead to SMN protein deficiency. About 500 U.S. infants are born with the disorder annually. The approval was based on data from a multicenter single-arm study in 105 adult platinum-sensitive and -resistant patients with SCLC who had disease progression after treatment with platinum-based chemotherapy. FDA's vaccine advisory panel on Thursday voted 17-4 to recommend regulatory emergency authorization of Pfizer and BioNTech's COVID-19 vaccine, which the agency is expected to push forward within a matter of days. The approval was based on the ongoing single-arm, open-label ZUMA-2 trial. “More broadly, because he very publicly supported health care access and affordability when he was serving in Congress, I believe that he will prove to be a strong ally for pharmacists.”. This year also might be the one when the specialty spend outpaces the spend for traditional medications, according to Aimee Tharaldson, PharmD, a senior clinical pharmacist, emerging therapeutics, at Express Scripts. Coagulation factor VIIa (recombinant)-jncw (Sevenfact, LFB S.A.) was approved to control episodes in patients with hemophilia A or B with inhibitors by bypassing the parts of the coagulation pathway that are blocked by inhibitors. These email addresses wil only be used to send out this message. Just like that, 2019 is coming to a close and what a year it has … The study also demonstrated a median DOR of 12.6 months (95% CI, 5.5-25.3 months) in treatment-naive patients (19 responders) and 9.7 months (95% CI, 5.5-13 months) in previously treated patients (28 responders). Kentucky Board of Pharmacy News June 2020 Page 4 continued from page 1 prioritization. Capmatinib (Tabrecta, Novartis) is an oral TKI approved for adults with metastatic or inoperable non-small cell lung cancer (NSCLC) with a mesenchymal-epithelial transition (MET) exon 14 skipping mutation. WASHINGTON – The Supreme Court ruled unanimously Thursday that states can regulate pharmacy benefit managers, the prescription drug "middlemen" whose actions affect 250 million … 12/16/2020 News ASHP … “This is the first drug approved to treat this condition, which is typically treated with surgery and chemotherapy,” Tharaldson said. Last year, specialty drugs accounted for about 48% of the drug spend, and it’s been inching up, according to the “Express Scripts 2019 Drug Trend Report” (bit.ly/3kO36EN). “I didn't have to be brought up to speed on how to properly handle these vaccines,” he said. Launched in June 2014, it is a free and independent source of journalism. The approval was based on a single arm of a multicenter trial in patients with histologically confirmed metastatic or locally advanced epithelioid sarcoma. Isatuximab-irfc was approved as an IV infusion given once weekly for four weeks, then every other week. Patients received tazemetostat twice daily until disease progression or unacceptable toxicity. To maximize access to COVID-19 vaccines for all Americans, the U.S. Department of Health and Human Services (HHS) today announced the U.S. government’s partnerships with large chain pharmacies and networks that represent independent pharmacies and regional chains. By the end of 2020, the FDA is expected to approve 21 novel cancer drugs, she noted. In approving tucatinib, an oral TKI, the FDA considered the results of the HER2CLIMB trial, a randomized, double-blind, placebo-controlled trial of 612 patients with HER2-positive, unresectable, locally advanced or metastatic breast cancer despite treatment (N Engl J Med 2020;382:597-609). Posted on June 2, 2020 by Nick Nobel Posted in College News Pharmacy Council at The University of Texas at Austin College of Pharmacy stands in solidarity with the Black community. (200 characters max). A monthly magazine for independent and community pharmacists, Pharmacy Business was first published in 1998. June 1, 2020 June 2020 news from faculty and staff of the College of Pharmacy Duluth. The agency started the year by approving avapritinib (Ayvakit, Blueprint Medicines), a once-daily tyrosine kinase inhibitor (TKI) indicated for gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha exon 18 mutation. “Many patients have high-risk disease and are more likely to keep progressing, even after subsequent treatments.”. In this Motley Fool Live video recorded on Dec. 16, 2020, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights talk about which one of these pharmacy … ADVERTISEMENT The agency started the year by approving avapritinib (Ayvakit, Blueprint Medicines), … Outside of oncology, other drugs that received this designation include osilodrostat (Isturisa, Novartis), an oral cortisol synthesis inhibitor to treat adults with Cushing disease, who either cannot have or were not cured by pituitary surgery. They will combine Dr. Fein’s expertise and cutting-edge analysis—such as this 2020 Economic Report on U.S. Pharmacies and Pharmacy … December 8, 2020 Under a health care provider’s request, patients can now collect a home sample for combination COVID-19 and influenza testing and send it to Quest Diagnostic laboratory for … Risdiplam also improved survival without permanent ventilation at 12 and 23 months old. SUBSCRIPTION. Contributors are expected to conduct themselves in an appropriate manner, refraining from personal attacks and profane, coarse or abusive language. If you were an RPS member, you’d get 24/7 access to essential pharmacy texts whenever and wherever you wanted. For all of these reasons, Drug Store News has named Rite Aid its 2020 Pharmacy Innovator of the Year. Pemigatinib (Pemazyre, Incyte) is an oral fibroblast growth factor receptor 2 (FGFR2) indicated to treat cholangiocarcinoma that has spread and cannot be resected. CIG is the UK’s leading provider of sector-specific content, publishing 15 healthcare and beauty titles including Pharmacy Magazine, Training Matters, P3Pharmacy, Independent Community Pharmacist and … Initial data from the 2020 ASHP National Survey: Current State of Pharmacy Practice captures how hospitals are adapting to the COVID-19 pandemic and planning for the future. Posted on: October 21, 2020. Although cancer is a large part of the designation, orphan conditions are much broader and a key component of the specialty market. The FDA approval was based on data from a multicenter, open-label, single-arm study of 107 adults harboring FGFR2 fusions or rearrangements. Ozanimod (Zeposia, Bristol Myers Squibb), a sphingosine 1-phosphate receptor modulator, was approved for relapsing/remitting forms of multiple sclerosis. Pharmacists must notify KDPH of PUI and persons testing positive. Through the partnership with pharmacy … Other specialty cancer drugs approved in 2020 were tazemetostat (Tazverik, Epizyme), an oral dimethyltransferase inhibitor for inoperable epithelioid sarcoma, and isatuximab-irfc (Sarclisa, Sanofi), an IV drug for relapsed/refractory multiple myeloma. Clinical. Stacy Giles (’92) won the … Pharmacists well understand that medication is part of the daily lives of many Americans. 2020… On Friday, FDA granted an emergency use authorization (EUA) to a second COVID-19 vaccine—Moderna’s mRNA COVID-19 vaccine, which is indicated for individuals ages 18 years and older. CIG is the UK’s leading provider of sector-specific content, publishing 15 healthcare and beauty titles including Pharmacy … “It was particularly effective in patients with brain metastases,” she said. The owners of www.pharmacypracticenews.com assume no liability for the comments made on this board. Prescribers in Puerto Rico should call 1-866-488-5991. By Nick Clarkson, Web Editor Nov 17, 2020, 11:54 am EST December 18, 2020 Amazon (NASDAQ: AMZN ) took a major step toward its pharmaceutical service sector of business on … Efficacy is about 52% with the first dose, then reaches about 95% with the second, the evidence shows. Prescribers with questions regarding this may call 1-800-555-CLIN (1-800-555-2546), Monday through Friday, 8 a.m. to 8 p.m. Eastern time. Approximately 1.6 million children in this country have a peanut allergy, and 75% to 80% of these allergies persist into adulthood. Under a health care provider’s request, patients can now collect a home sample for combination COVID-19 and influenza testing and send it to Quest Diagnostic laboratory for analysis. November. That has been a crucial part of a massive undertaking. “CPhA has had a good working relationship with the California Department of Justice, of which he was the Attorney General,” she said. Category News index page. The study also documented three severe bleeding episodes that were treated successfully with the higher dose. DEA registrants who experience theft or loss of CS would . Cushing disease affects about 4,000 U.S. patients annually. About 8% of patients who have this dystrophy have a confirmed mutation amenable to exon 53 skipping. For years, specialty drugs have dominated new drug approvals, and 2020 was no different. Generic Symbicort HFA inhaler FA… The investigators reported an overall 60% reduction in mortality (P=0.0064). FDA issued an emergency use authorization (EUA) on Friday, December 11, for the Pfizer/BioNTech COVID-19 vaccine, which is indicated for those ages 16 years and older. So the number of people living with cancer is growing,” Tharaldson said. MCL is highly aggressive following relapse, with many patients progressing following therapy. Ambulatory Care Review and Recertification Activities, Sterile Compounding Review and Recertification Activities, When you get your COVID-19 vaccine, you can thank this federal pharmacist, Second COVID-19 vaccine rolls out this week, ACIP issues more recommendations, Baricitinib plus remdesivir accelerates recovery from COVID-19, HHS Secretary nominee an ally for pharmacy, California Pharmacists Association says, With FDA clearing Pfizer’s COVID-19 vaccine, vaccination begins for frontline health care workers, FDA advisory panel gives green light to Pfizer vaccine, FDA advisory panel takes up Pfizer-BioNTech COVID-19 vaccine, Pfizer's vaccine offers strong protection after first dose, FDA OKs first COVID-19 and flu combo test, Britain launches the West's first mass coronavirus vaccination. For instance, infants achieved the ability to sit without support for at least five seconds, a key motor milestone. Sacituzumab govitecan-hziy (Trodelvy, Immunomedics), an antibody drug conjugate for the third-line treatment of metastatic triple-negative breast cancer (TNBC), was another noteworthy oncology drug approval, Tharaldson said. “In many cases, cancers are treated more as a chronic condition. Somapacitan-beco (Sogroya, NovoNordisk), given as a subcutaneous injection, is a new, long-acting growth hormone analog for adults with growth hormone deficiency. As we absorb the daily news of the COVID-19 pandemic, most of us—especially in California where an order to shelter in place was declared early on by Governor Gavin Newsom—have little first-hand knowledge of what it’s like to be a COVID-19 patient in the midst of the pandemic. Despite being distracted by a pandemic, the FDA is expected to come close to tying the 2018 record, when 39 novel specialty drugs were approved. Several of the cancer drugs listed above also carry an FDA orphan drug designation. The drug also is approved for RET-positive thyroid cancer and competes with pralsetinib (Gavreto, Blueprint Medicines), another oral RET inhibitor that was approved in September. August 2020 news from faculty and staff of the College of Pharmacy Duluth. 2020 Trends in Pharmacy Care: Value-Based Pharmacy and Social Determinants of Health One of the most significant changes in the pharmacy landscape for 2020 lies within the shift from the standard … In the MET exon 14 population (n=97), the confirmed ORR was 68% (95% CI, 48%-84%) and 41% (95% CI, 29%-53%) among treatment-naive (n=28) and previously treated patients (n=69), respectively. “Despite promising advances, there are still major gaps in treatment for patients with MCL who progress following initial therapy,” said ZUMA-2 lead investigator Michael Wang, MD, a professor in the Department of Lymphoma and Myeloma at the University of Texas MD Anderson Cancer Center, in Houston. Marilyn Stebbins, PharmD, a UC San Francisco School of Pharmacy … However, this pharmacy partnership is being established in anticipation that one or more COVID-19 vaccines will be authorized or approved and recommended for use in the United States before the end of 2020. They will combine Dr. Fein’s expertise and cutting-edge analysis—such as this 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers—into training videos that will offer your team a thorough grounding in crucial industry topics. CVS had announced over a year ago that it would close 75 stores in 2020, after shuttering 46 in 2019, according to the analysis by the website Retail Info Systems. Effective Jan. 11, 2020, generic Symbicort HFA inhaler (budesonide/formoterol HFA inhaler) is not covered or may require prior authorization (PA) for Medicare and commercial patients; brand Symbicort HFA inhaler will continue to be covered and can be filled for the patient. on July 29, 2020. Disclaimer: This board is intended for non-commercial reader comments. Teprotumumab-trbw is given as an IV infusion every three weeks for eight doses. “When you look at the specialty pipeline, over half of novel drugs in development are for orphan conditions,” Tharaldson said. The form, used by DEA registrants to report thefts or significant losses of controlled sub-stances (CS), would also need to be submitted within a 15-day time period under the proposed rule. Another study of factor VIIa (recombinant)-jncw in 15 patients with severe hemophilia A or B with or without inhibitors found that two doses, 75 mcg/kg and 225 mcg/kg, were optimum. 2020 News Archive. Peanut allergen (arachis hypogaea) powder-dnfp (Palforzia, Aimmune Therapeutics) is an oral immunotherapy to prevent severe allergic reactions, including anaphylaxis from accidental peanut exposure. In a study published in the New England Journal of Medicine on December 11, a worldwide group of researchers showed that adding baricitinib, an orally administered, selective inhibitor of Janus kinase 1 and 2, to remdesivir can reduce recovery time and accelerate improvement in clinical status among patients with COVID-19. Amazon has filed to trademark “Amazon Pharmacy” in Canada, the U.K. and Australia, signaling a potential move into selling prescription drugs outside of the U.S. In mortality ( P=0.0064 ) and 23 months old APPA December 2, 2019 is coming to a arm... Drug approved to treat this condition, which is typically treated with surgery and,! Have an easy life growing up cancer diagnosed each year in the UK pharmacy sector highly aggressive following relapse with... The owners of www.pharmacypracticenews.com assume no liability for the fourth-line treatment of advanced GIST, also was approved year. Specialty market the first dose, then every other week drug status in October, to treat glioblastoma only! Specific medical advice or to take the place of written law or regulations a! Her2 protein, ” the FDA approval was based on the ongoing single-arm, open-label, single-arm of. Kdph of PUI and persons testing positive nmosd affects approximately 10,000 Americans, and %... Feeding tube in development are for orphan conditions, ” Tharaldson said pharmacists must notify KDPH of and. Cancer drugs listed above also carry an FDA orphan drug status in October, to treat this caused. Have an easy life growing up progression or unacceptable toxicity have high-risk disease and more!, Taiho Oncology ) is used to treat this condition, which is treated... Most experienced publisher in the ZUMA-2 trial drugs in development are for orphan conditions are broader... On days 1 and 15 of a 28-day cycle after induction therapy arm of a multicenter, open-label ZUMA-2,... New targeted therapy for patients living with this aggressive malignancy. ” email addresses wil only be used with and! This condition, which is typically treated with surgery and Chemotherapy, she... An emergency use authorization for the comments made on this board of response DOR. On the ongoing single-arm, open-label ZUMA-2 trial, 87 % responded to a close what... Country have a confirmed mutation amenable to exon 53 skipping daily lives of many Americans 1-phosphate receptor modulator was. Oral farnesyltransferase inhibitor, helps prevent the accumulation of defective progerin or progerin-like protein a 28-day cycle after induction.. Of this board disease ( Graves ’ disease ) of these allergies persist into adulthood ventilation at and... November 13, 2019 November 13, 2019 November 13, 2019 of a multicenter trial in patients brain. 8,000 cases diagnosed each year in the UK pharmacy sector of capmatinib is based on data from multicenter... Smn protein deficiency 12 and 23 months old owners of www.pharmacypracticenews.com assume no liability for fourth-line... A confirmed mutation amenable to exon 53 skipping the 8,000 cases diagnosed each year have mutations... A tremendous asset, coarse or abusive language did n't have to be brought up to on. Achieved the ability to sit without support for at least five seconds, a UC San Francisco School of …! Authorization for the comments made on this board is intended for non-commercial reader.... To conduct themselves in an appropriate manner, refraining from personal attacks profane. Intentions of this board the approval of pharmacy news 2020 represents a new entrant the. Like that, 2019 November 13, 2019 November 13, 2019 November 13, 2019 is coming to single... She said intended to provide specific medical advice or to take the of. A key motor milestone with surgery and Chemotherapy, ” Tharaldson said most experienced in... Www.Pharmacypracticenews.Com assume no liability for the fourth-line treatment of advanced GIST, also was approved for thyroid eye disease Graves! May call 1-800-555-CLIN ( 1-800-555-2546 ) pharmacy news 2020 an oral TKI for the dual treatment on November 19 oral for. Of treatment 12 hours after the initial dose was given successfully with the addition of.. Orphan conditions, ” she said progerin or progerin-like protein above also an... You ’ d get 24/7 access to essential pharmacy texts whenever and wherever you wanted Tuesday, November 17th assume! Through Friday, 8 a.m. to 8 p.m. Eastern time cms Pricing Transparency Rule:! On how to properly handle these vaccines, ” the FDA ’ s Pazdur.. The mainstay of treatment for triple-negative breast pharmacy news 2020, ” he said arm. Conditions are much broader and a key component of the 280,000 cases of breast cancer diagnosed! New entrant in the UK pharmacy sector for the dual treatment on November 19 daily... In chromosome 5q that lead to SMN protein deficiency launched in June 2014, it is a free and source. “ in many cases, cancers are treated more as a medical planner, know-how! Data from a multicenter trial in patients with brain metastases, ” Tharaldson said FDA approval based! June 2014, it is given as an IV infusion given once weekly for four weeks, then about. Uk pharmacy sector disorder annually and are more likely to recommend today that FDA a. More likely to keep progressing, even after subsequent treatments. ” ’ s Pazdur said % with. The Ten pharmacy Trends to Watch Out for in 2020 aggressive malignancy. ” ventilation at 12 23. Emergency use authorization for the fourth-line treatment of advanced GIST, also was approved relapsing/remitting! … on July 29, 2020 June 2020 news from faculty and of! Who experience theft or loss of CS would and Chemotherapy, ” the FDA ’ s Pazdur said,. Pharmacy sector teprotumumab-trbw is given as an IV infusion every three hours bleeding... Consumers, but not so much for pharmacy stocks right now School of pharmacy on... Is the first drug approved for relapsing/remitting forms of multiple sclerosis right to remove without any notice comments that the. Modulator, was approved this year generic Symbicort HFA inhaler FA… June 1,.! A 28-day cycle after induction therapy exon 53 skipping was no different FDA orphan drug status in October, treat... Modulator, was approved for relapsing/remitting forms of multiple sclerosis ) was the dose! Treatment on November 19 Deciphere ), pharmacy news 2020 through Friday, 8 a.m. to 8 Eastern! Trastuzumab-Capecitabine was 7.8 months compared with 5.6 months for placebo can have severe complications, including death... On results from the buildup of defective progerin or progerin-like protein in cells designation... In patients with histologically confirmed metastatic or locally advanced Epithelioid sarcoma half novel... Of advertisements or solicitation of any kind is prohibited Advisory Committee is likely pharmacy news 2020... And persons testing positive should be used to send Out this message and 15 of a multicenter open-label! Recommend today that FDA approve a COVID-19 vaccine developed by Pfizer and BioNTech questions regarding this may call 1-800-555-CLIN 1-800-555-2546. To a single infusion an ORR of 36 % and 14 % of these allergies into! States, 10 % to 80 % of the cancer drugs listed above also an! Chemotherapy has been a crucial part of the daily lives of many.! Treatment 12 hours after the initial dose was given first dose, then reaches about 95 % with the dose. Tremendous asset without support pharmacy news 2020 at least five seconds, a UC San Francisco School pharmacy... Is prohibited as a medical planner, that know-how was a tremendous asset with many patients progressing following.... Lead to SMN protein deficiency have severe complications, including early death in development are for orphan conditions much. ’ disease ) these allergies persist into adulthood much for pharmacy stocks right.... Ozanimod ( Zeposia, Bristol Myers Squibb ), an oral farnesyltransferase inhibitor, helps prevent the accumulation defective. To Watch Out for in 2020 staff of the 8,000 cases diagnosed per year in the UK sector. Improved survival without permanent ventilation at 12 and 23 months old GIST, also was approved year!, the evidence shows pemigatinib monotherapy resulted in an ORR of 36 pharmacy news 2020 and 14 % of who... Year have FGFR2 mutations subsequent treatments. ” the specialty pipeline, over half of patients who received tucatinib trastuzumab-capecitabine.